Back to Agenda
DESTRUCTION AND RETENTION AT CLINICAL SITES
Session Chair(s)
Betsy Fallen, RN
Consultant
BAFallen Consulting LLC, United States
As the pharmaceutical industry moves to a primarily digital environment, most clinical sites are left with file cabinets, boxes and perhaps rooms of paper generated for past trials. It is understood that the documents are controlled by the site, but who owns the retention decision and financially supports it has long been a question with different interpretations. The decision to retain the paper can have both a regulatory and legal ingredients with a perhaps dash of reluctance added for interest. We will present a case study from one sponsor company who has adopted a global process to provide answers to the sites burdened with paper as part of the overall look at site based documentation.
Speaker(s)
Essential Documents at the Clinical Site: Please retain until we say STOP
Betsy Fallen, RN
BAFallen Consulting LLC, United States
Consultant
Site View of SDR
Lisa Mulcahy
Mulcahy Consulting, LLC, United States
Owner, Principal Consultant
Site View of SDR
Ashley Smith
TransPerfect Translations, United States
Project Manager, Life Sciences
Have an account?